Discover how Discngine has transformed Bayer CropScience's data management system with Discngine Assay resulting in a significant boost in Bayer's scientific research capabilities, enabling more time for innovation and less for manual data troubleshooting.
Read MoreDigital technologies are reshaping the landscape of discovery and innovation. L’Oréal has been leading the charge in embracing digital transformation and data-driven processes. Collaborating with Discngine, they've successfully migrated multiple of their scientific software applications to the cloud, enhancing research and innovation. Join us as we hear from project leaders Ludwig Baux and Diane Genest about their journey of migrating the screening assay data management software at L’Oréal.
Read MoreSee how Discngine contributed to the success of over 100 Medicinal Chemists from one of the Top 5 Pharma by building and implementing custom solution for Building Blocks data management
Read MoreSanofi assesses over 1000 potentially mutagenic or genotoxic impurities per year. Until recently, these assessments used to imply a lot of manual operations from its scientists. Alexander Amberg, Head of in silico toxicology, and Alain Grelier, Digital product owner, shared how we collaborated to drastically streamline the in silico hazard assessment of these impurities.
Read MoreAs an official KNIME Partner, we at Discngine are extremely happy that the work accomplished with our client CENTOGENE resulted in a KNIME Success Story. Read more to discover the story behind the project!
Read MoreCloud environment can bring a lot of benefits, to research-driven organizations, but shifting from an on-premises (local) to a Cloud environment can be challenging and sometimes scary. This article will outline an example of a French Biotech Startup that migrated its scientific software applications toolset to the Cloud and reveal the real-life advantages of this migration that exceeded expectations.
Read MoreManuel Cases Thomas, a Medicinal chemistry consultant and director at Senechaem was looking for a solution to help him use the full potential of data at hand and generate new design ideas. In this interview, he shares how 3decision® makes a difference in his daily work: from a scientific need to the impact on design ideas and successful project outcomes.
Read MoreThe continuous increase in the available 3D structural data brings along changes in the medicinal chemistry field. Dr. George Sheppard, Senior Principal Research Scientist at AbbVie, shared his thoughts on the benefits for medicinal chemists using 3D information, current challenges and limitations, and proposed potential ways for improvement, in the following interview.
Read More